`
`Washington, D.C.
`
`In the Matter of
`
`CERTAIN HUMAN MILK
`OLIGOSACCHARIDES AND METHODS
`OF PRODUCING THE SAME
`
`Inv. No. 337-TA-1120
`_
`
`i
`
`ORDER NO. 9:
`
`NON-PARTY
`OF
`MOTION
`UNOPPOSED
`GRANTING
`FRIESLANDCAMPINA INGREDIENTS NORTH AMERICA,
`INC.
`FOR A SECOND EXTENSION OF TIME TO MOVE TO LIMIT,
`QUASH, OR OTHERWISE RESPOND TO SUBPOENA DUCES
`TECUM AND AD TESTIFICANDUM
`
`(September 4, 2018)
`
`On August 31, 2018, non-party FrieslandCampina Ingredients North America,
`
`Inc.
`
`(“FCINA”) moved (1120-O05) to extend the deadline to respondto and/or move to limit or quash
`
`the subpoenas duces tecum and ad testlficandum served by Respondent Jennewein Biotechnologie
`
`GmbH. FCINA requests that it receive an extension up to and including September ll, 2018.
`
`(Mot. at 1-2.) FCINA explains:
`
`FCINA and its outside counsel requires additional time to continue
`their investigation of the document requests contained in the subpoena
`duces tecum. FCINA also seeks the additional time to negotiate with
`Respondent to reach mutual agreement on the scope of the document
`requests and deposition.
`FCINA and Respondent have had
`discussions and FCINA is hopeful
`that through these discussions,
`FCINA and Respondent can come to a mutual understanding
`regarding the scope of FClNA’s response to the subpoenas and
`therefore avoid motion practice.
`If, however, negotiations fail, an
`extension of time will allow FCINA to draft motions to limit or quash
`the subpoenas. Since there are still approximately two months left in
`fact discovery, the requested extension of time will not cause any
`prejudice to Respondent.
`l
`
`(Id. at -2.) FCINA represents that Respondent Jennewein Biotechnologie GmbH, Complainant
`
`Glycosyn LLC, and the Commission Investigative Staff do not oppose the motion. (Id. at 1.)
`
`-1.
`
`
`
`1
`
`Good cause having been shown and there being no opposition, FCINA-’smotion (1120-005)
`
`is hereby granted.
`
`'
`
`'
`
`,
`
`,
`
`SO ORDERED.
`
`arles E. Bullock
`Chief Administrative Law Judge
`
`_2_
`
`
`
`CERTAIN HUMAN MILK OLIGOSACCHARIDES AND
`METHODS OF PRODUCING THE SAME
`
`INV. NO. 33.7-TA-1120
`
`PUBLIC CERTIFICATE OF SERVICE
`
`I, Lisa R. Barton, hereby certify that the attached Order N0. 9 has been served by hand upon the
`Commission Investigative Attorney, Lisa Murray, Esq. and the following parties as indicated,
`
`on
`
`_
`
`SEPU__l:ZUlB
`
`_
`
`—
`
`_
`
`Lisa R. Barton, Secretary
`U.S. International Trade Commission
`500 E Street SW, Room 112A
`Washington, D.C. 20436
`
`,
`
`FOR COIVIPLAINANT GLYCOSVN LLC
`
`Michael C. Newman, Esq.
`MINTZ LEVIN COHN FERRIS GLOVSKY
`AND POPEO PC
`One Financial Center
`Boston, MA. O21 1 1
`
`_
`
`Via Hand Delivery
`Express Delivery
`Via First Class Mail
`Other:
`
`FOR RESPONDENT JENNEWEIN BIOTECHNOLOGIE GmbH
`
`Gary M. Hnath, Esq.
`MAYER BROWN, LLP
`1999 K “Street,NW
`Washington, DC 20006
`
`Via Hand Delivery
`Express Delivery
`Via First Class Mail
`Other:
`
`FOR NON-PARTY FRIESLANDCAMPINA INGREDIENTS NORTH AMERICA,
`INC.
`Y
`
`D. Sean Trainor
`O’MELVENY & MYERS LLP
`_1625 Eye Street NW
`Washington, DC 20006
`
`Via Hand Delivery
`Express Delivery
`Via First Class Mail
`Other:
`"
`
`